Quantcast

Latest WuXi PharmaTech Stories

2014-09-10 20:24:21

LONDON, Sept. 10, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Biotech API Manufacturing Services: World Industry and Market 2014-2024https://www.reportbuyer.com/product/2006105/Biotech-API-Manufacturing-Services-World-Industry-and-Market-2014-2024.html Report DetailsOutsourced biopharma production - new analysis announcing revenue prospectsWhat's the outlook for making biological active pharma ingredients (APIs) under contract? Visiongain's new report...

2014-08-18 08:28:40

SHANGHAI, Aug. 18, 2014 /PRNewswire/ -- WuXiPharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, announced today that a manufacturing facility of WuXi's wholly owned subsidiary Shanghai SynTheAll Pharmaceutical Co. Ltd. (STA) passed an FDA inspection in July for the manufacture of the active pharmaceutical ingredient (API) for a branded commercial drug. This...

2014-08-13 16:26:06

SHANGHAI, Aug. 13, 2014 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading research and development services company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United States, today announced its financial results for the second quarter of 2014. Second-Quarter 2014 Highlights -- Net Revenues Increased 14.8% Year Over Year to $163.4 Million -- Laboratory Services Net Revenues Grew 13.2% Year Over Year...

2014-08-08 08:25:42

SHANGHAI, Aug. 8, 2014 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE:WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations in China and the United States, today announced the appointment of Walter Teh-Ming Kwauk as an independent director to the Board of Directors. Mr. Kwauk will serve on the Audit Committee. Mr. Kwauk is currently a senior consultant at Motorola Solutions (China) Co., Ltd. He serves as a director of Thunder...

2014-07-22 08:31:25

SHANGHAI, July 22, 2014 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the second quarter of 2014 after the New York Stock Exchange closes on Wednesday, August 13, 2014 (which will be Thursday morning, August 14, 2014 Shanghai time). The earnings release will be available on the...

2014-07-08 16:25:39

SHANGHAI, July 8, 2014 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations in China and the United States, today announced that Ying Han has stepped down from the WuXi Board of Directors for personal reasons. Ms. Han has served on WuXi's board since 2008. WuXi has begun a search for a new board member to complete Ms. Han's term of office. The audit committee, of which Ms. Han...

2014-06-23 08:28:11

SHANGHAI, June 23, 2014 /PRNewswire/ -- More than 400 life science innovators recently tuned in to a global webinar hosted by WuXi AppTec to gain insights into the advancement of programs that ultimately have been designated by the U.S. Food and Drug Administration as breakthrough therapies. The breakthrough designation applies to specific drugs that treat serious medical conditions and show signs of substantial improvements over available therapies, and it enables their speedy...

2014-06-20 08:23:21

SHANGHAI, June 20, 2014 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations in China and the United States, today announced that its toxicology facility in Suzhou recently passed a surveillance Good Laboratory Practice (GLP) inspection by the U.S. Food and Drug Administration (FDA) with no major observations. This was the first FDA GLP inspection in the facility's five years of...

2014-06-18 12:38:03

LONDON, June 18, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Drug Discovery Outsourcing: World Market Forecast 2014-2024 & Future Prospects for Leading Companieshttp://www.reportbuyer.com/pharma_healthcare/drug_discovery/drug_discovery_outsourcing_world_market_forecast_2014_2024_future_prospects_leading_companies.html Report DetailsDrug discovery outsourcing - discover trends and segments with highest revenue potentialWhat does the future hold...

2014-05-28 08:31:07

SHANGHAI, May 28, 2014 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations in China and the United States, today announced that its manufacturing subsidiary, Syn-The-All Pharmaceutical Co., Ltd. (STA), has begun operation of a high-potency active pharmaceutical ingredient (HPAPI) laboratory in Shanghai, thereby adding HPAPI processing to its portfolio of services. The lab will...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related